The design of a study’s protocol is pivotal to its success in clinical trials, and engaging study sites early in this process can significantly enhance outcomes. In this interview, we sit down with Chris Herrick, VP for Research Systems and Technology at Mass General Brigham, a leading academic healthcare system based in Boston, United States, to discuss the importance of site involvement, the challenges of exclusion, and the potential for improved trial success through collaboration.